Comparison between Eldorado Agritech IPO and Molbio Diagnostics IPO.
Eldorado Agritech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Molbio Diagnostics IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Eldorado Agritech IPO is up to ₹1,000.00 Cr whereas the issue size of the Molbio Diagnostics IPO is up to ₹0.00 Cr. The final issue price of Eldorado Agritech IPO is and of Molbio Diagnostics IPO is .
| Eldorado Agritech IPO | Molbio Diagnostics IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹340.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 0 shares | 1,25,56,000 shares |
| OFS Issue Size (Amount) | up to ₹660.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹1,000.00 Cr | up to ₹0.00 Cr |
Eldorado Agritech IPO opens on , while Molbio Diagnostics IPO opens on . The closing date of Eldorado Agritech IPO and Molbio Diagnostics IPO is , and , respectively.
Eldorado Agritech IPO P/E ratio is , as compared to Molbio Diagnostics IPO P/E ratio of .
| Eldorado Agritech IPO | Molbio Diagnostics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Eldorado Agritech Ltd.'s revenue increased by 25% and profit after tax (PAT) rose by 47% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Molbio Diagnostics Ltd.'s revenue increased by 22% and profit after tax (PAT) rose by 66% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 46.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.60% | 16.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 23.75% | 20.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 33.58% | 15.23% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Eldorado Agritech IPO Retail Individual Investors (RII) are offered 0 shares while in Molbio Diagnostics IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Eldorado Agritech IPO and 0 shares in Molbio Diagnostics IPO.
| Eldorado Agritech IPO | Molbio Diagnostics IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Eldorado Agritech IPO subscribed in total, whereas Molbio Diagnostics IPO subscribed .
